Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-28

Clinical Trial Update: Clinical Efficacy of H.P. Acthar Gel 80 U/ml to Improve the Signs and Symptoms in Subjects With Dry Eye Disease [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the efficacy of H.P. Acthar Gel 80 U/ml for improving signs and symptoms in subjects with Dry Eye Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • H.P. ACTHAR GEL

Snippet

Sponsor: Toyos Clinic | Conditions: Dry Eye Disease | Phase 4 | Status: COMPLETED | Results posted: 2021-01-28